Trusted by:

clients clients clients clients clients clients clients clients clients clients
Release date: 18-Nov-2024 12:30 PM EST
California wildfires have become more severe, killing more trees, UC Irvine researchers find
University of California, Irvine

Irvine, Calif., Nov. 18, 2024 — The severity of California’s wildfires has rapidly increased over the last several decades as a result of human-driven climate change, resulting in accelerated tree losses during more intense wildfires, an Environmental Research Letters study from University of California, Irvine and the University of Utah scientists reveals.

Release date: 18-Nov-2024 12:00 PM EST
Expert Available: Spirit Airlines Files for Bankruptcy
George Washington University

The airline says it will continue to operate while it restructures its debt. ...

Release date: 18-Nov-2024 12:00 PM EST
Expert Available: Trump’s Controversial Cabinet Picks Set Stage for Senate Showdown
George Washington University

Donald Trump’s Cabinet selections, including Matt Gaetz, Tulsi Gabbard, Pete Hegseth, and Robert F. Kennedy Jr., are drawing criticism over qualifications and past controversies. ...

Release date: 18-Nov-2024 12:00 PM EST
Expert Available: Organic Carrots Linked to E.coli Outbreak
George Washington University

The CDC reports, one person has died and dozens have tested positive for E. coli after eating organic carrots. ...

Newswise: Children’s Hospital of Philadelphia Researchers Announce Promising Results from First-of-its-Kind, Multicenter, Phase 1 Gene Therapy Trial for Danon Disease
Release date: 18-Nov-2024 11:55 AM EST
Children’s Hospital of Philadelphia Researchers Announce Promising Results from First-of-its-Kind, Multicenter, Phase 1 Gene Therapy Trial for Danon Disease
Children's Hospital of Philadelphia

Researchers at Children’s Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy trial for Danon disease (DD), a rare, X-linked heart condition caused by a single gene mutation. The phase 1 trial was a collaboration between CHOP and the University of California, San Diego Medical Center, the University of Colorado, Anschutz Medical Center, Boston Children's Hospital and Rocket Pharmaceuticals. The data on the results of the RP-A501 Phase 1 trial, presented at a late breaking session today at the American Heart Association Scientific Sessions 2024 in Chicago, were also published in the New England Journal of Medicine.

Release date: 18-Nov-2024 11:15 AM EST
اختبار مبتكَر من مايو كلينك قد يحسن معدل الكشف عن ورم المتوسطة في الدم
Mayo Clinic

طور باحثو مايو كلينك استراتيجية اختبار مبتكَرة للكشف عن ورم المتوسطة، قد تسهم في زيادة معدل الكشف عن الحمض النووي السرطاني في الدم. تركز هذه الطريقة على الأقسام المُعاد ترتيبها أو المُبدلة من الحمض النووي في خلايا ورم المتوسطة السرطانية، والتي تُعرف بإعادة ترتيب الكروموسومات.

Newswise: Suicide Rates for Young Male Cancer Survivors Triple in Recent Years
Released: 18-Nov-2024 11:00 AM EST
Suicide Rates for Young Male Cancer Survivors Triple in Recent Years
Keck Medicine of USC

New research published in JAMA Network Open from Keck Medicine of USC, which includes USC Norris Comprehensive Cancer Center, suggests that among all cancer survivors, male adolescents or young adults (AYA) have the highest rate of death by suicide.

Newswise: CLA Celebrates Success of First In-Person
“How to Start a Laundromat” Workshop in Illinois
Release date: 18-Nov-2024 10:55 AM EST
CLA Celebrates Success of First In-Person “How to Start a Laundromat” Workshop in Illinois
Coin Laundry Association

CLA Celebrates Success of First In-Person “How to Start a Laundromat” Workshop in Illinois

Release date: 18-Nov-2024 10:50 AM EST
Teste inovador da Mayo Clinic pode melhorar a taxa de detecção de mesotelioma no sangue
Mayo Clinic

Pesquisadores da Mayo Clinic desenvolveram uma estratégia de testes inovadora para a mesotelioma que pode ser capaz de aumentar a taxa de detecção do DNA do câncer no sangue.

Released: 18-Nov-2024 10:25 AM EST
Prueba innovadora de Mayo Clinic puede mejorar la tasa de detección de mesotelioma en la sangre
Mayo Clinic

Investigadores de Mayo Clinic han desarrollado una estrategia de pruebas innovadoras para el mesotelioma que puede aumentar la tasa de detección del ADN del cáncer en la sangre.


close
1.83651